Vanguard Group Inc Harrow Health, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Harrow Health, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,866,875 shares of HROW stock, worth $79.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,866,875
Previous 1,840,710
1.42%
Holding current value
$79.2 Million
Previous $38.5 Million
118.28%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding HROW
# of Institutions
177Shares Held
21.4MCall Options Held
845KPut Options Held
717K-
Opaleye Management Inc. Boston, MA3.99MShares$169 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$91.8 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$91.2 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$31 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA723KShares$30.7 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.15B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...